Amicus Therapeutics Inc. (NASDAQ:FOLD): An Opportunity for Fundamental Investors?
Amicus Therapeutics Inc. (NASDAQ:FOLD) previous close was $10.20 while the outstanding shares total 264.37M. The firm has a beta of 1.11. FOLD’s shares traded lower
Amicus Therapeutics Inc. (NASDAQ:FOLD) previous close was $10.20 while the outstanding shares total 264.37M. The firm has a beta of 1.11. FOLD’s shares traded lower
Amicus Therapeutics Inc. (NASDAQ:FOLD) shares fell to a low of $10.645 before closing at $10.72. Intraday shares traded counted 2.12 million, which was 21.65% higher
Amicus Therapeutics Inc. (NASDAQ:FOLD) shares fell to a low of $9.96 before closing at $10.38. Intraday shares traded counted 2.25 million, which was 20.07% higher
Amicus Therapeutics Inc. (NASDAQ:FOLD) shares fell to a low of $9.20 before closing at $9.26. Intraday shares traded counted 2.32 million, which was 22.86% higher
© All rights reserved
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.